Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

ATDC mediates a TP63-regulated basal cancer invasive program.

Palmbos PL, Wang Y, Bankhead Iii A, Kelleher AJ, Wang L, Yang H, Ahmet ML, Gumkowski ER, Welling SD, Magnuson B, Leflein J, Lorenzatti Hiles G, Abel EV, Dziubinski ML, Urs S, Day ML, Ljungman ME, Simeone DM.

Oncogene. 2019 May;38(18):3340-3354. doi: 10.1038/s41388-018-0646-9. Epub 2019 Jan 14.

2.

Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma.

Stempel DA, Szefler SJ, Pedersen S, Zeiger RS, Yeakey AM, Lee LA, Liu AH, Mitchell H, Kral KM, Raphiou IH, Prillaman BA, Buaron KS, Yun Kirby S, Pascoe SJ; VESTRI Investigators.

N Engl J Med. 2016 Sep 1;375(9):840-9. doi: 10.1056/NEJMoa1606356.

3.

ATDC/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic Mechanisms.

Palmbos PL, Wang L, Yang H, Wang Y, Leflein J, Ahmet ML, Wilkinson JE, Kumar-Sinha C, Ney GM, Tomlins SA, Daignault S, Kunju LP, Wu XR, Lotan Y, Liebert M, Ljungman ME, Simeone DM.

Cancer Res. 2015 Dec 1;75(23):5155-66. doi: 10.1158/0008-5472.CAN-15-0603. Epub 2015 Oct 15.

4.

ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis.

Wang L, Yang H, Abel EV, Ney GM, Palmbos PL, Bednar F, Zhang Y, Leflein J, Waghray M, Owens S, Wilkinson JE, Prasad J, Ljungman M, Rhim AD, Pasca di Magliano M, Simeone DM.

Genes Dev. 2015 Jan 15;29(2):171-83. doi: 10.1101/gad.253591.114.

5.

ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells.

Wang L, Yang H, Palmbos PL, Ney G, Detzler TA, Coleman D, Leflein J, Davis M, Zhang M, Tang W, Hicks JK, Helchowski CM, Prasad J, Lawrence TS, Xu L, Yu X, Canman CE, Ljungman M, Simeone DM.

Cancer Res. 2014 Mar 15;74(6):1778-88. doi: 10.1158/0008-5472.CAN-13-2289. Epub 2014 Jan 27.

6.

The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children.

Berger WE, Leflein JG, Geller DE, Parasuraman B, Miller CJ, O'Brien CD, O'Dowd L.

Allergy Asthma Proc. 2010 Jan-Feb;31(1):26-39. doi: 10.2500/aap.2010.31.3301.

PMID:
20167143
8.

A randomized, controlled trial to investigate the effect of ciclesonide and beclomethasone dipropionate on eye lens opacity.

Chylack LT Jr, Gross GN, Pedinoff A; Ciclesonide Lenticular Safety Study Group.

J Asthma. 2008 Dec;45(10):893-902. doi: 10.1080/02770900802353636.

PMID:
19085579
9.

Severe exacerbations and decline in lung function in asthma.

O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW; START Investigators Group.

Am J Respir Crit Care Med. 2009 Jan 1;179(1):19-24. doi: 10.1164/rccm.200807-1126OC. Epub 2008 Oct 31. Erratum in: Am J Respir Crit Care Med. 2010 Oct 1;182(7):983-4.

PMID:
18990678
10.

The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma.

Busse WW, Pedersen S, Pauwels RA, Tan WC, Chen YZ, Lamm CJ, O'Byrne PM; START Investigators Group.

J Allergy Clin Immunol. 2008 May;121(5):1167-74. doi: 10.1016/j.jaci.2008.02.029. Epub 2008 Apr 11.

PMID:
18405951
11.

Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.

Meltzer EO, Stahlman JE, Leflein J, Meltzer S, Lim J, Dalal AA, Prillaman BA, Philpot EE.

Clin Ther. 2008 Feb;30(2):271-9. doi: 10.1016/j.clinthera.2008.02.005.

PMID:
18343265
12.

Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma.

O'Byrne PM, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, Ullman A, Lamm CJ, Pauwels RA; START Investigators Group.

Chest. 2006 Jun;129(6):1478-85.

PMID:
16778264
13.

Safety features of budesonide inhalation suspension in the long-term treatment of asthma in young children.

Leflein JG, Baker JW, Eigen H, Lyzell E, McDermott L.

Adv Ther. 2005 May-Jun;22(3):198-207.

PMID:
16236681
14.

Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.

Akerlund A, Andersson M, Leflein J, Lildholdt T, Mygind N.

J Allergy Clin Immunol. 2005 Mar;115(3 Suppl 1):S460-82. Review.

PMID:
15746883
15.

Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.

Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, Ullman A, Lamm CJ, O'Byrne PM; START Investigators Group.

Lancet. 2003 Mar 29;361(9363):1071-6.

PMID:
12672309
16.

Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial.

Leflein JG, Szefler SJ, Murphy KR, Fitzpatrick S, Cruz-Rivera M, Miller CJ, Smith JA.

Pediatrics. 2002 May;109(5):866-72.

PMID:
11986448
17.

Safety of budesonide inhalation suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young children with persistent asthma.

Leflein JG, Gawchik SM, Galant SP, Lyzell E, Young M, Cruz-Rivera M, Walton-Bowen K, Smith JA, Fitzpatrick S.

Allergy Asthma Proc. 2001 Nov-Dec;22(6):359-66.

PMID:
11775393
18.

Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.

Fish JE, Karpel JP, Craig TJ, Bensch GW, Noonan M, Webb DR, Silverman B, Schenkel EJ, Rooklin AR, Ramsdell JW, Nathan R, Leflein JG, Grossman J, Graft DF, Gower RG, Garay SM, Frigas E, Degraff AC, Bronsky EA, Bernstein DI, Berger W, Shneyer L, Nolop KB, Harrison JE.

J Allergy Clin Immunol. 2000 Nov;106(5):852-60.

PMID:
11080706
19.

Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma.

Mellon M, Leflein J, Walton-Bowen K, Cruz-Rivera M, Fitzpatrick S, Smith JA.

Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):593-8.

PMID:
10934092
20.

Delivery of glucocorticoids by jet nebulization: aerosol characteristics and output.

Leflein J, Brown E, Hill M, Kelly HW, Loffert DT, Nelson HS, Szefler SJ.

J Allergy Clin Immunol. 1995 May;95(5 Pt 1):944-9.

PMID:
7751514

Supplemental Content

Loading ...
Support Center